(News Bulletin 247) – Deutsche Bank announced on Tuesday that it had lowered its price target on Eurofins Scientific from 56 to 54 euros, while renewing its ‘sell’ recommendation on the stock.
After looking at the accounts of the group’s 280 subsidiaries in Europe in order to better understand its business model, the analyst deduces that the bio-analysis giant will have to significantly improve its performance. in all its business lines in order to be able to achieve its objectives by 2027.
However, he argues, such a phenomenon has never happened from a historical point of view, with the sole exception of the Covid crisis which had given a boost to the diagnostics industry.
‘In view of these elements, we remain cautious about the reality of an improvement of such magnitude,’ he underlines.
Copyright (c) 2023 News Bulletin 247. All rights reserved.
I have over 8 years of experience working in the news industry. I have worked as a reporter, editor, and now managing editor at 247 News Agency. I am responsible for the day-to-day operations of the news website and overseeing all of the content that is published. I also write a column for the website, covering mostly market news.
